Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma SafiledCriticalAlmirall Prodesfarma Sa
Priority to UY0001032953ApriorityCriticalpatent/UY32953A/en
Publication of UY32953ApublicationCriticalpatent/UY32953A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Derivados de la piridazin-3(2H)-ona inhibidores de la fosfodiesterasa 4, terapéuticamente útiles en el tratamiento , la prevención o la supresión de asma, enfermedad obstructiva crónica y otras enfermedades susceptibles de ser mejoradas mediante la inhibición de la PDE4, procedimientos para la preparación de dichos derivados y composiciones farmacéuticas que los contienenDerivatives of pyridazin-3 (2H) -one phosphodiesterase 4 inhibitors, therapeutically useful in the treatment, prevention or suppression of asthma, chronic obstructive disease and other diseases that can be improved by inhibiting PDE4, procedures for the preparation of said derivatives and pharmaceutical compositions containing them
UY0001032953A2005-06-202010-10-15
NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA
UY32953A
(en)
Compounds derived from piperidino-dihydrothienopyrimidines; pde4 inhibitors; pharmaceutical composition comprising them; and use in the treatment of disorders or diseases of the respiratory or gastrointestinal routes, as well as inflammatory diseases of the joints or eyes, among others.
compound, pharmaceutical composition, methods for inhibiting the action of glycogen synthase kinase-3, and for treating, preventing or ameliorating a disease, use of a compound, and article of manufacture